MyAverix Finance
SHG · Healthcare
Tianjin Tianyao Pharmaceuticals Co Ltd (600488)
Drug Manufacturers - Specialty & Generic
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $4.73B, P/E ratio is 216.50, net margin is 0.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600488
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — FAQ
What is Tianjin Tianyao Pharmaceuticals Co Ltd's market cap?
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a reported market cap of $4.73B (data as of 2026-03-28).
What is 600488's P/E ratio?
The price-to-earnings (P/E) ratio for Tianjin Tianyao Pharmaceuticals Co Ltd (600488) is 216.50 (data as of 2026-03-28).
Does Tianjin Tianyao Pharmaceuticals Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Tianjin Tianyao Pharmaceuticals Co Ltd (600488). Check the MyAverix Finance app for the latest dividend data.
What sector is Tianjin Tianyao Pharmaceuticals Co Ltd in?
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600488 listed on?
600488 is listed on SHG.
What is Tianjin Tianyao Pharmaceuticals Co Ltd's net margin?
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) reports a net margin of 0.6% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.